Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2019-12-05 17:45 |
Valneva rencontrera investisseurs et partenaires potentiels lors de la 38ème J.…
|
French | 295.4 KB | ||
| 2019-11-28 07:00 |
Valneva : l’EMA approuve une prolongation de la durée d’utilisation du vaccin I…
|
French | 399.4 KB | ||
| 2019-11-28 07:00 |
Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months
|
English | 394.8 KB | ||
| 2019-11-18 07:00 |
Valneva Reports Excellent Final Phase 1 Results for its Chikungunya Vaccine Can…
|
English | 426.5 KB | ||
| 2019-11-18 07:00 |
Valneva publie d’excellents résultats finaux de Phase 1 pour son candidat vacci…
|
French | 707.5 KB | ||
| 2019-11-13 18:00 |
Valneva annonce la nomination de deux experts des vaccins à son Conseil Scienti…
|
French | 331.5 KB | ||
| 2019-11-13 18:00 |
Valneva Announces Appointments of Two Leading Vaccine Experts to its Scientific…
|
English | 327.6 KB | ||
| 2019-11-06 18:00 |
Déclaration d'actions et de droits de vote de la société Valneva SE - Octobre 2…
|
French | 205.4 KB | ||
| 2019-10-31 07:00 |
Valneva Raises Product Sales Guidance Following Strong Nine-Month Results and R…
|
English | 793.0 KB | ||
| 2019-10-31 07:00 |
Valneva révise en hausse sa prévision de croissance des ventes de produits pour…
|
French | 809.8 KB | ||
| 2019-09-30 08:30 |
Valneva: Recrutement terminé pour les études de Phase 2 du candidat vaccin cont…
|
English | 22.4 KB | ||
| 2019-09-30 08:30 |
Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine C…
|
English | 20.1 KB | ||
| 2019-09-30 08:30 |
Valneva: Recrutement terminé pour les études de Phase 2 du candidat vaccin cont…
|
French | 447.7 KB | ||
| 2019-09-30 08:30 |
Valneva Completes Recruitment for Phase 2 Studies of its Lyme Disease Vaccine C…
|
English | 448.1 KB | ||
| 2019-09-19 18:45 |
Valneva confirme le retrait de ses actions de la Bourse de Vienne
|
English | 14.3 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
